Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ubiquitech Software Corp. (UBQU) Explores Strategic Merger Opportunities in the Growing Specialty Materials and Advanced Textile Manufacturing Industry
-
Stardust Expands Across Ontario's Cottage Country with New Franchise Serving Muskoka, Kawartha Lakes, Peterborough and Haliburton
-
FACE FOUNDRIÉ Opens in Los Gatos, Marking the Facial Bar's First South Bay Area Location
-
iMerit, an EXL Company, launches iMerit Scholars platform as AI talent war shifts to domain expertise
-
Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly
-
CBD of Denver, Inc. Announces Operating Business Relaunch Following BioCannabis Agreement and New International Supply Contracts
-
Business First Bancshares, Inc. Announces Financial Results for Q3 2026
-
HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP)
-
Consolidated Water Sets Investor Conference Call to Discuss Third Quarter 2026 Results on Tuesday, November 10, 2026 at 11:00 a.m. ET
-
IQST - IQSTEL Closes Two-Year Non-Convertible Financing for Ultranet, a Profitable $131 Million-Revenue West African Telecom Platform Expected to Make IQSTEL Cash-Flow Positive on a Consolidated Basis
-
PSB Holdings, Inc. Reports Quarterly Earnings of $0.94 Per Share
-
Worldwide NFT, Inc. Announces Signing LOI to Acquire Federal Cybersecurity Provider
-
Citizens Community Bancorp, Inc. Reports Third Quarter 2026 Earnings of $0.56 Per Share; Board Approves 14% Increase in Quarterly Dividend to $0.12 per Share
-
Neurocrine Biosciences Presents New Analysis Establishing Benchmark for Clinically Meaningful Change in Overall Health Reported by Patients with Tardive Dyskinesia
-
Fuel Tech Announces Air Pollution Control Contracts Valued at Approximately $3.3 Million
-
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
-
Hallador Energy Company Schedules Third Quarter 2026 Conference Call for November 9, 2026 at 5:00 p.m. ET
-
Everybody's Optimizing: Why "Maxxing" is Dictionary.com's 2026 Word of the Year
-
Quantum Computing Inc. to Host Third Quarter 2026 Financial Results and Company Update Call on Monday, November 9, 2026
-
Cleary Gottlieb Names 31 New Partners and Counsel
-
Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
-
Vantive Announces Expansion of HomeAdvantage and Highlights New Evidence to Advance Home Dialysis During Kidney Week
-
Bank of Marin Bancorp Reports Third Quarter Financial Results Driven by Loan Growth, NIM Expansion and Higher Earnings
-
Star Equity Holdings Expands Energy Services Division with Machine Shop Acquisition in Vernal, Utah
-
ESMO 2026: Key Findings for Cancer Care and Drug Development, Upcoming Webinar Hosted by Xtalks
-
Apex Fintech Solutions Partners with EDX Markets to Support Digital Markets Expansion
-
Advancing Diabetes Clinical Trials Through Integrated Technology and Operational Oversight, Upcoming Webinar Hosted by Xtalks
-
Illinois Lottery Achieves Record Sales, Generates Funding for K-12 Education
-
Beyond ctDNA: EVPs and the Future of Early Cancer Detection, Upcoming Webinar Hosted by Xtalks
-
Scienjoy Holding Corporation Reports Second Quarter and First Half 2026 Unaudited Financial Results
-
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.05 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $15 Billion
-
Dario Expands Contract with a Leading Regional Grocery Retailer, Adding Women's Digital Health and Clinical Care Program
-
Audi and Universal Display Celebrate 10 Years of OLED Technology in Audi Production Vehicles
-
Empery Digital Resumes Share Repurchases and Provides Update on Capital Allocation Priorities and Midwest Data Center Investment
-
Propanc Biopharma Publishes New Data: PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells & Restores Therapeutic Vulnerability
-
Savaria Announces Date for Third Quarter 2026 Financial Results
-
Boston Omaha Corporation Completes Sale of its Surety Insurance Business Unit to CopperPoint Insurance Company
-
XTEND Reports Preliminary Third Quarter 2026 Results, Names Former Navy SEAL Captain Matt McGraw U.S. CEO, and Issues Letter to Shareholders
-
Intrepid Selected for USDA Matching Grant Award to Support Carlsbad Sulfate of Potash Project
-
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Digimarc Returns from RGCA with Strong Market Interest in Its Next-Generation Gift Card Security
-
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
-
ACMC Partners with AI Resource Intelligence Company Scepter to Evaluate Critical Minerals Projects
-
Herc Holdings Inc. Announces CEO Succession Plan
-
Paradium.AI to Host Third Quarter 2026 Financial Results Conference Call on Monday, November 9, 2026
-
MasterBrand Announces CFO Transition
-
AAR increases size and extends maturity of revolving credit facility
-
Delcath Systems to Host Third Quarter 2026 Earnings Call
-
New Indigenous Graduates Ready for Careers in Clean Water
-
Critical Metals Corp. Acquisition of European Lithium Approved by Supreme Court of Western Australia
